Literature DB >> 19457998

The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.

John B Johnson1, Ken Grant, Griffith D Parks.   

Abstract

The complement system is a critical component of the innate immune response that all animal viruses must face during natural infections. Our previous results have shown that treatment of the paramyxovirus simian virus 5 (SV5) with human serum results in deposition of complement C3-derived polypeptides on virion particles. Here, we show that the virion-associated C3 component includes the inactive form iC3b, suggesting that SV5 may have mechanisms to evade the host complement system. Electron microscopy, gradient centrifugation, and Western blot analysis indicated that purified SV5 virions derived from human A549 cells contained CD46, a plasma membrane-expressed regulator of complement that acts as a cofactor for cleavage and inactivation of C3b into iC3b. In vitro cleavage assays with purified complement components showed that SV5 virions had C3b cofactor activity, resulting in specific factor I-mediated cleavage of C3b into inactive iC3b. SV5 particles generated in CHO cells, which do not express CD46, did not have cofactor activity. Conversely, virions derived from a CHO cell line that was engineered to overexpress human CD46 contained elevated levels of virion-associated CD46 and displayed enhanced C3b cofactor activity. In comparison with C3b, purified SV5 virions had very low cofactor activity against C4b, consistent with the known preference of CD46 for C3b versus C4b. Similar results were obtained for the closely related mumps virus (MuV), except that MuV particles derived from CHO-CD46 cells had higher C4b cofactor activity than SV5 virions. In neutralization assays with human serum, SV5 and MuV containing CD46 showed slower kinetics and more resistance to neutralization than SV5 and MuV that lacked CD46. Our results support a model in which the rubulaviruses SV5 and MuV incorporate cell surface complement inhibitors into progeny virions as a mechanism to limit complement-mediated neutralization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457998      PMCID: PMC2708606          DOI: 10.1128/JVI.00713-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster.

Authors:  M K Liszewski; T W Post; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  Human mannose-binding protein functions as an opsonin for influenza A viruses.

Authors:  K L Hartshorn; K Sastry; M R White; E M Anders; M Super; R A Ezekowitz; A I Tauber
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

3.  Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.

Authors:  G J Kotwal; B Moss
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

4.  Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.

Authors:  T McNearney; L Ballard; T Seya; J P Atkinson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

5.  Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity.

Authors:  E M Adams; M C Brown; M Nunge; M Krych; J P Atkinson
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

6.  Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing.

Authors:  S M Russell; R L Sparrow; I F McKenzie; D F Purcell
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

7.  Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).

Authors:  T Masaki; M Matsumoto; I Nakanishi; R Yasuda; T Seya
Journal:  J Biochem       Date:  1992-05       Impact factor: 3.387

8.  Measles virus receptor properties are shared by several CD46 isoforms differing in extracellular regions and cytoplasmic tails.

Authors:  D Gerlier; B Loveland; G Varior-Krishnan; B Thorley; I F McKenzie; C Rabourdin-Combe
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

9.  Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype.

Authors:  T W Post; M K Liszewski; E M Adams; I Tedja; E A Miller; J P Atkinson
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity.

Authors:  W L Fodor; S A Rollins; S Bianco-Caron; R P Rother; E R Guilmette; W V Burton; J C Albrecht; B Fleckenstein; S P Squinto
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  20 in total

1.  Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Authors:  Donald R Latner; Marcia McGrew; Nobia J Williams; Sun B Sowers; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

Review 2.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

Review 3.  Paramyxovirus activation and inhibition of innate immune responses.

Authors:  Griffith D Parks; Martha A Alexander-Miller
Journal:  J Mol Biol       Date:  2013-09-20       Impact factor: 5.469

4.  Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion.

Authors:  Moanaro Biswas; John B Johnson; Sandeep R P Kumar; Griffith D Parks; Subbiah Elankumarana; Elankumaran Subbiah
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

5.  Interactions of human complement with virus particles containing the Nipah virus glycoproteins.

Authors:  John B Johnson; Hector C Aguilar; Benhur Lee; Griffith D Parks
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

6.  Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and vesicular stomatitis virus to neutralization.

Authors:  John B Johnson; Douglas S Lyles; Martha A Alexander-Miller; Griffith D Parks
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

7.  Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59.

Authors:  Derek Leaderer; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  J Gene Med       Date:  2015 Jun-Jul       Impact factor: 4.565

8.  Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization.

Authors:  Yujia Li; John B Johnson; Griffith D Parks
Journal:  Virology       Date:  2016-08-06       Impact factor: 3.616

9.  Point mutations in the paramyxovirus F protein that enhance fusion activity shift the mechanism of complement-mediated virus neutralization.

Authors:  John B Johnson; Anthony P Schmitt; Griffith D Parks
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

10.  Activation of innate anti-viral immune response genes in symptomatic benign prostatic hyperplasia.

Authors:  A A Madigan; K M Sobek; J L Cummings; W R Green; D J Bacich; D S O'Keefe
Journal:  Genes Immun       Date:  2012-09-06       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.